人工智能增强的粉样PET图像的粉样量化
Pierrick Bourgeat1, Jurgen Fripp1, Leo Lebrat2
1Australian eHealth Research Centre, CSIRO Health and Biosecurity, Brisbane, QLD, Australia.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|February 11, 2026
概括
深度SUVR是一种人工智能方法,通过降低可变性和提高跨标记物和研究的一致性来增强粉样蛋白PET量化. 这一进步有助于临床决策,并检测出微妙的粉样蛋白变化.
科学领域:
- 神经成像是一种神经成像.
- 人工智能的人工智能
- 生物标志物 生物标志物
背景情况:
- 百叶状体尺度是粉状体PET量化标准,但面临着跟踪器和扫描器可变性的挑战.
- 准确的粉样蛋白量化对于阿尔茨海默病的研究和临床应用至关重要.
研究的目的:
- 引入DeepSUVR,这是一种新的深度学习方法,用于纠正粉样蛋白PET扫描中的粉样蛋白量化.
- 提高粉样蛋白PET数据在不同标记器,扫描仪和研究中的一致性和可靠性.
主要方法:
- DeepSUVR采用深度学习方法,在训练过程中惩罚不可思议的纵向轨迹.
- 该模型在AIBL/ADNI的大型数据集 (7,149个扫描) 上进行了训练,并在10个外部数据集中的15,807个扫描上进行了验证.
- 该方法学习标准化吸收值比率 (SUVR) 校正因子,而不需要推断的纵向数据.
主要成果:
- DeepSUVR在粉样蛋白阴性个体中增加了痕迹相关性和降低了变异性.
- 它与认知表现,视觉阅读和神经病理学有更强烈的关联.
- 该方法显著改善了纵向一致性,并增加了检测与治疗相关的粉样蛋白变化的效果大小.
结论:
- DeepSUVR显著提升了粉样PET的量化,超过了标准方法.
- 这种人工智能驱动的方法对于临床决策和检测早期或微妙的粉样蛋白积累至关重要.
- DeepSUVR提供了一个实用的替代方案,可以集成到现有的PET成像管道中.
相关概念视频
Amyloid Fibrils
12.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Amyloid Fibrils
6.5K
6.5K
Self-Evaluation: Self-Enhancement and Self-Verification
5.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Bioavailability Enhancement: Drug Solubility Enhancement
273
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
273
Bioavailability Enhancement: Drug Permeability Enhancement
213
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
213
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
226
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
226

![Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62460.jpg&w=3840&q=50)
